Karin Haider
A 24 week, randomized, double-blind, multicenter, placebo-controlled efficacy, safety, tolerability and PK trial of Nilotinib (AMN107) in pulmonary arterial hypertension (PAH)
Feb 1, 2012
Clinical Studies - Feb 1, 2012 - Apr 1, 2014
Aborted
Project leader: Brutsche Martin
Members: Burger Barbara, Haider Karin
The obstructive pulmonary disease outcomes cohort of Switzerland (TOP DOCS): phenotypes and vascular amage in COPD
Jan 1, 2012Prospective cohort study including COPD patients from 6 study centers in Northern Switzerland
Fundamental Research - Jan 1, 2012 - Dec 31, 2015
Automatically Closed
Project leader: Brutsche Martin
Members: Rüdiger Jochen, Burger Barbara, Haider Karin
A multicenter, double-blind, placebo-controlled phase 3 study to demonstrate the efficacy and safety of ACT-293987 in patients with pulmonary arterial hypertension
Oct 1, 2009The primary objective is to demonstrate the effect of ACT-293987 on time to first clinical worsening in patients with pulmonary arterial hypertension (PAH)
Clinical Studies - Oct 1, 2009 - Apr 1, 2013
Aborted
Project leader: Brutsche Martin
Members: Burger Barbara, Haider Karin, Rüdiger Jochen
A phase IIIb multicenter, 52 week treatment, randomized, blinded, double dummy, parallel group efficacy study comparing the effect of inhaled indacaterol 150ug o.d. vs inhaled tiotropium 18ug o.d. on lung function, rate of exacerbations and related outcomes in patients with COPD
Jul 1, 2009
Clinical Studies - Jul 1, 2009 - Jul 1, 2011
Completed
Project leader: Brutsche Martin
Members: Haider Karin, Burger Barbara